Blockchain Registration Transaction Record
Creative Biolabs Innovates Drug Design for COVID-19 with Spike Protein Focus
Creative Biolabs introduces cutting-edge methods for COVID-19 drug design, focusing on the spike protein of SARS-CoV-2. Learn about their pseudovirus neutralization assay and stable cell lines for vaccine development and antibody screening.

This news highlights the crucial advancements in drug and vaccine development for COVID-19 by targeting the spike protein of the SARS-CoV-2 virus. Creative Biolabs' innovative approaches provide more efficient and safer methods for testing antiviral agents, screening antibodies, and developing vaccines, ultimately contributing to the global efforts in combating the pandemic.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xbabfce1bc1e9c029b5663ffed79f72f4ead2b21c6d4e2365a6ee42b60c31a93a |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | pendZLMq-2e5d0911f172b5f306365d1ec47526a2 |